Try our Advanced Search for more refined results

August 16, 2017

Cephalon, Inc. et al v. Slayback Pharma Limited Liability Company et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. July 06, 2020

    Generics' Bid To Limit IP Loss 'Makes No Sense,' Judge Says

    A Delaware federal judge on Monday extended his finding that generic-drug makers infringed valid claims for patents covering Teva's cancer drug Bendeka to dozens of untried patent claims, saying pretrial agreements to do so applied no matter which side won. 

1 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login